Concepedia

Steffi Lehmann

SL

10

Publications

1K

Citations

10

H-Index

2009

Active since

Affiliations

Institute for Biomedical Engineering(Current)

ETH Zurich

Roche (Switzerland)

University of Zurich

Radboud University Nijmegen

Steffi Lehmann is an author at Institute for Biomedical Engineering specializing in medicine, cancer research, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2009–2024

10

Publications

10

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 342 citations · Full text

Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response

Anika Nagelkerke, Johan Bussink, Hilda Mujčić et al. · Breast Cancer Research · 2013 · 225 citations · Full text

Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells

Steffi Lehmann, Veronika te Boekhorst, Julia Odenthal et al. · Current Biology · 2017 · 145 citations · Full text

, , +14

A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents

Sylvia Herter, Laura Morra, Ramona Schlenker et al. · Cancer Immunology Immunotherapy · 2016 · 136 citations · Full text

<i>In Vivo</i> Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell–Mediated Tumor Killing

Steffi Lehmann, Ramanil Perera, Hans-Peter Grimm et al. · Clinical Cancer Research · 2016 · 65 citations

Rows per page

1–5 of 10